Home > Toyota Research Institute Introduces Advanced Safety Research Vehicle - Platform 2.0 | AutoMotoTV

Auto
Toyota Research Institute Introduces Advanced Safety Research Vehicle - Platform 2.0 | AutoMotoTV

Description

Subscribe for more car videos: http://bitly/AutoMotoTV Toyota Research Institute Introduces Advanced Safety Research Vehicle - Platform 2.0 | AutoMotoTV ...

Added on the 08/03/2017 20:53:22 - Copyright : Auto Moto EN

To customise your video :

Or Create an account

More videos on the subject

  • New Research Studies Covid-19 Brain Damage

    New research out is looking to bring us closer to understanding how covid-19 can cause brain damage. The study suggests that while the viral infection may not directly reach the brain in most cases... ...It can spark the sort of destructive inflammation that’s seen with other neurological conditions. The research was conducted by U.S. government scientists at the National Institutes of Health. The team studied the brains of 19 people who died after contracting covid-19, says Gizmodo. The researchers found clogged, thinned out, and leaky blood vessels as well as inflammation.

    31/12/2020 - Wochit
  • Study Links Heart-Healthy Lifestyle With Decreased Likelihood Of Dementia

    A new study says better heart health in middle age may help reduce a person's risk significantly for dementia later in life. Researchers at Sweden's Karolinska Institute studied 1,449 Finns enrolled in the Finnish Cardiovascular Risk Factors, Aging, and Dementia study. Adults with 'ideal' results on several cardiovascular health metrics were found to be 86% less likely to be diagnosed with dementia than those with lower scores. According to UPI, the metrics considered included smoking history, engagement in physical activity, body weight, cholesterol levels, and blood pressure. The findings suggest that maintaining lifelong heart health by not smoking, exercising regularly, and staying slim may reduce dementia risk later in life.

    15/12/2020 - Wochit
  • Another 100 Million Doses Of COVID-19 Vaccine Bought By US Government

    The US government has ordered another 100 million doses of Moderna's coronavirus vaccine. This brings the total number of vaccines ordered to 200 million, says Business Insider. If the vaccine receives emergency-use authorization from the FDA, Moderna plans to deliver. The delivery will be for 20 million doses by the end of December with the rest over the start of 2021. The US still has the option to purchase another 300 million doses from Moderna. Everyone who wants the vaccine should be able to get one, timing is the main concern.

    12/12/2020 - Wochit
  • Pfizer's Covid-19 Vaccine Wins Crucial Vote

    The covid-19 vaccine developed by Pfizer and BioNTech is one big step closer to the public. A group of outside experts assembled by the FDA largely voted to recommend the vaccine. The vaccine was recommended for emergency use in people ages 16 and older. The over eight-hour advisory committee meeting featured presentations and discussions. However, several members said they were uncomfortable recommending its use to people ages 16-17. The limited data available right now, according to Gizmodo.

    11/12/2020 - Wochit
  • Men Are More Likely To Die From COVID-19

    Men infected with COVID-19 are nearly three times as likely to require intensive care unit treatment. They also have a far higher risk for death from the virus than women, says UPI. The findings of this study are leading researchers to ask why these differences exist. Scientists will most likely use this knowledge to inform their fight against COVID-19. Researchers estimate that men account for more than half of those infected with the new coronavirus. However, this could be because men are more likely to develop symptoms.

    10/12/2020 - Wochit
  • Pfizer COVID-19 Vaccine Offers Protection Within 10 Days Of Being Vaccinated

    Pfizer's COVID-19 vaccine confers more than 50% protection against the virus within 10 days of receiving the first dose. Pfizer, which developed the vaccine with BioNTech, said the vaccine was more than 95% after 2 doses. The two vaccine doses are intended to be administered 21 days apart. According to UPI, data suggests that the vaccine is effective for everyone regardless of weight or age. The U.S. federal government has agreed to purchase enough of the vaccine to inoculate 50 million people.

    09/12/2020 - Wochit